Kröner PT, Picco MF, Cangemi JR et al. The burden of vaccine-preventable diseases in patients with inflammatory bowel disease. J Clin Gastroenterol 2022;56:798–804.

Article  PubMed  Google Scholar 

Solitano V, Facciorusso A, Jess T et al. Comparative risk of serious infections with biologic agents and oral small molecules in inflammatory bowel diseases: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2023;21:907–21.e2.

Article  CAS  PubMed  Google Scholar 

Farraye FA, Melmed GY, Lichtenstein GR, Kane SV. Acg clinical guideline: Preventive care in inflammatory bowel disease. Am J Gastroenterol 2017;112:241–258.

Article  PubMed  Google Scholar 

Jones JL, Tse F, Carroll MW et al. Canadian association of gastroenterology clinical practice guideline for immunizations in patients with inflammatory bowel disease (ibd)-part 2: inactivated vaccines. J Can Assoc Gastroenterol 2021;4:e72–e91.

Article  PubMed  PubMed Central  Google Scholar 

Kucharzik T, Ellul P, Greuter T et al. Ecco guidelines on the prevention, diagnosis, and management of infections in inflammatory bowel disease. J Crohn’s Colitis 2021;15:879–913.

Article  CAS  Google Scholar 

Loras C, Gisbert JP, Mínguez M et al. Liver dysfunction related to hepatitis b and c in patients with inflammatory bowel disease treated with immunosuppressive therapy. Gut 2010;59:1340–1346.

Article  CAS  PubMed  Google Scholar 

Park SH, Yang SK, Lim YS et al. Clinical courses of chronic hepatitis b virus infection and inflammatory bowel disease in patients with both diseases. Inflamm Bowel Dis 2012;18:2004–2010.

Article  PubMed  Google Scholar 

Schillie S, Vellozzi C, Reingold A et al. Prevention of hepatitis b virus infection in the united states: recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep 2018;67:1–31.

Article  Google Scholar 

Leuridan E, Van Damme P. Hepatitis b and the need for a booster dose. Clin Infect Dis 2011;53:68–75.

Article  PubMed  Google Scholar 

West DJ, Calandra GB. Vaccine induced immunologic memory for hepatitis b surface antigen: implications for policy on booster vaccination. Vaccine 1996;14:1019–1027.

Article  CAS  PubMed  Google Scholar 

Bruce MG, Bruden D, Hurlburt D et al. Protection and antibody levels 35 years after primary series with hepatitis b vaccine and response to a booster dose. Hepatology 2022;76:1180–1189.

Article  CAS  PubMed  Google Scholar 

Bruce MG, Bruden D, Hurlburt D et al. Antibody levels and protection after hepatitis b vaccine: results of a 30-year follow-up study and response to a booster dose. J Infect Dis. 2016. https://doi.org/10.1093/infdis/jiv748.

Article  PubMed  PubMed Central  Google Scholar 

Ritscher AM, LeClair-Netzel M, Friedlander NJ et al. Cross-sectional study of hepatitis b antibody status in health care workers immunized as children at an academic medical center in wisconsin. Vaccine 2020;38:1597–1600.

Article  CAS  PubMed  Google Scholar 

Simons BC, Spradling PR, Bruden DJ et al. A longitudinal hepatitis b vaccine cohort demonstrates long-lasting hepatitis b virus (hbv) cellular immunity despite loss of antibody against hbv surface antigen. J Infect Dis 2016;214:273–280.

Article  CAS  PubMed  PubMed Central  Google Scholar 

https://www.Ema.Europa.Eu/en/documents/assessment-report/heplisav-b-epar-public-assessment-report_en.Pdf.

Scientific Working Group on Viral Hepatitis Prevention, Department of Health, Hong Kong Sar Government. Recommendations on hepatitis b vaccination regimens in Hong Kong-consensus of the Scientific Working Group on viral hepatitis prevention. 2004

World Health O. Hepatitis b vaccines: who position paper, July 2017—recommendations. Vaccine 2019;37:223–225.

Article  Google Scholar 

Immunization NACo. Update on the recommended use of hepatitis b vaccine.

Are booster immunisations needed for lifelong hepatitis b immunity? European consensus group on hepatitis b immunity. Lancet. 355:561–565.

Gisbert JP, Chaparro M. Vaccination strategies in patients with ibd. Nat Rev Gastroenterol Hepatol 2013;10:277–285.

Article  CAS  PubMed  Google Scholar 

Gisbert JP, Menchén L, García-Sánchez V et al. Comparison of the effectiveness of two protocols for vaccination (standard and double dosage) against hepatitis b virus in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2012;35:1379–1385.

Article  CAS  PubMed  Google Scholar 

Chaparro M, Gordillo J, Domènech E et al. Fendrix vs engerix-b for primo-vaccination against hepatitis b infection in patients with inflammatory bowel disease: a randomized clinical trial. Am J Gastroenterol 2020;115:1802–1811.

Article  PubMed  Google Scholar 

Kochhar GS, Mohan BP, Khan SR et al. Hepatitis-b vaccine response in inflammatory bowel disease patients: a systematic review and meta-analysis. Inflamm Bowel Dis 2021;27:1610–1619.

Article  PubMed  Google Scholar 

deBruyn JCC, Soon IS, Fonseca K et al. Serologic status of routine childhood vaccines, cytomegalovirus, and epstein-barr virus in children with inflammatory bowel disease. Inflamm Bowel Dis 2019;25:1218–1226.

Article  PubMed  Google Scholar 

Moses J, Alkhouri N, Shannon A et al. Hepatitis b immunity and response to booster vaccination in children with inflammatory bowel disease treated with infliximab. Am J Gastroenterol 2012;107:133–138.

Article  CAS  PubMed  Google Scholar 

Pratt PK, David N, Weber HC et al. Antibody response to hepatitis b virus vaccine is impaired in patients with inflammatory bowel disease on infliximab therapy. Inflamm Bowel Dis 2018;24:380–386.

Article  PubMed  Google Scholar 

Watts A, Bennett WE, Molleston JP et al. Incidence of low seroimmunity to hepatitis b virus in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2017;65:551–554.

Article  PubMed  Google Scholar 

Schillie SF, Murphy TV. Seroprotection after recombinant hepatitis b vaccination among newborn infants: a review. Vaccine 2013;31:2506–2516.

Article  CAS  PubMed  Google Scholar 

Doi H, Kanto T. Factors influencing the durability of hepatitis b vaccine responses. Vaccine 2021;39:5224–5230.

Article  CAS  PubMed  Google Scholar 

Wang Z-Z, Gao Y-H, Lu W et al. Long-term persistence in protection and response to a hepatitis b vaccine booster among adolescents immunized in infancy in the western region of china. Hum Vaccine Immunother 2017;13:909–915.

Article  Google Scholar 

Averhoff F, Mahoney F, Coleman P et al. Immunogenicity of hepatitis b vaccines: implications for persons at occupational risk of hepatitis b virus infection. Am J Prev Med 1998;15:1–8.

Article  CAS  PubMed  Google Scholar 

Drachman R, Isacsohn M, Rudensky B, Drukker A. Vaccination against hepatitis b in children and adolescent patients on dialysis. Neph Dial Transplant 1989;4:372–374.

Article  CAS  Google Scholar 

Shaw FE, Guess HA, Roets JM et al. Effect of anatomic injection site, age and smoking on the immune response to hepatitis b vaccination. Vaccine 1989;7:425–430.

Article  PubMed  Google Scholar 

Centers for Disease Control and Prevention. A comprehensive immunization strategy to eliminate transmission of hepatitis b virus infection in the United States. Recommendations of the advisory committee on immunization practices (acip) part II: Immunization of adults. MMWR Morb Mortal Wkly Rep 2006;55:1–33.

Google Scholar 

Wisconsin Department of Health and Family Services Division of Public Health. Immunizations: Wisconsin immunization registry. https://www.dhs.wisconsin.gov/immunization/wir.htm, 2023

Centers for Disease Control and Prevention. Immunization information systems (iis). https://www.cdc.gov/vaccines/programs/iis/index.html.

Koepke R, Petit AB, Ayele RA et al. Completeness and accuracy of the wisconsin immunization registry: an evaluation coinciding with the beginning of meaningful use. J Public Health Manage Pract 2015;21:273–281.

Article  Google Scholar 

Schell TL, Richard LJ, Tippins K et al. High but inequitable covid-19 vaccine uptake among patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 2022;20:1606–8.e2.

Article  CAS  PubMed